Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
4.180
-0.080 (-1.88%)
At close: Feb 21, 2025, 4:00 PM
4.250
+0.070 (1.67%)
After-hours: Feb 21, 2025, 6:00 PM EST
Codexis Employees
Codexis had 174 employees as of December 31, 2023. The number of employees decreased by 74 or -29.84% compared to the previous year.
Employees
174
Change (1Y)
-74
Growth (1Y)
-29.84%
Revenue / Employee
$370,379
Profits / Employee
-$356,851
Market Cap
340.16M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
CDXS News
- 8 days ago - Codexis Announces New Employment Inducement Grants - GlobeNewsWire
- 9 days ago - Codexis to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27th - GlobeNewsWire
- 16 days ago - Codexis Appoints Arthur Levin, PhD, to Strategic Advisory Board - GlobeNewsWire
- 5 weeks ago - Codexis Appoints Christos Richards to Board of Directors - GlobeNewsWire
- 3 months ago - Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 3 months ago - Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics - GlobeNewsWire
- 3 months ago - Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors - GlobeNewsWire
- 3 months ago - Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics - GlobeNewsWire